Project Information

Code Project Title Financing Institution Lead Year of Project Start
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI) Medical Research Agency dr Aleksandra Gąsecka - van der Pol
A multicentre, randomized, double-blind, placebo-controlled clinical trial evaluating the effect of intestinal microbiota transplantation as an inflammatory response modulator (immunomodulation), included in standard therapy Medical Research Agency dr n. med. Jarosław Biliński
Evaluation of the efficacy and safety of empagliflozin in the treatment of neutropenia in patients with glycogenosis 1b "- EMPAtia Medical Research Agency dr Piotr Sobieraj
Polish Chimeric Antigen Receptor T-cell Network Medical Research Agency dr hab. n. med. Radosław Zagożdżon (Kierownik Projektu) / prof. dr hab. Sebastian Giebel (Główny Badacz)
Evaluation of the effect of fenofibrate on the function of pancreatic beta cells in children with newly diagnosed type 1 diabetes Medical Research Agency prof. dr hab. Agnieszka Szypowska
The use of platelet-rich leukocyte fibrin as a stimulator of the angiogenesis process in patients undergoing revascularization due to critical ischemia of the lower limbs Medical Research Agency prof. dr hab. Zbigniew Gałązka
Evaluation of the effectiveness of topical treatment with budesonide in children with Crohn's disease with localization in the esophagus and/or stomach and/or duodenum Medical Research Agency prof. dr hab. n. med. Aleksandra Banaszkiewicz
Use of anti-CD19 CAR-T lymphocytes in the treatment of adult patients with relapsed and refractory acute lymphoblastic leukemia. Phase I / II clinical trial Medical Research Agency prof. dr hab. Grzegorz Basak
Evaluation of the efficacy and safety of Nebivolol in the treatment of hypertension in adolescents Medical Research Agency dr hab. Małgorzata Pańczyk-Tomaszewska
Multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rapamycin in drug-resistant epilepsy associated with tuberous sclerosis Medical Research Agency prof. dr hab. n. med. Sergiusz Jóźwiak
EMpagliflozin and daPAgliflozin in patients hospiTalized for acute decompensated Heart failure (EMPATHY trial) Medical Research Agency Prof. dr hab. Marek Postuła Prof. dr hab. Jolanta Siller-Matula
Randomized, double-blind clinical trial evaluating the safety and efficacy of rapamycin versus vigabatrin in the prophylactic treatment of infants with tuberous sclerosis Medical Research Agency prof. dr hab. Sergiusz Jóźwiak
Assessment of the safety and efficacy of an advanced therapy medicinal product containing living ASCs in the treatment of diabetic foot syndrome - a randomized, double-blind study (FootCell) Medical Research Agency prof. dr hab. n. med. Małgorzata Lewandowska-Szumieł
Phase 2a non-commercial and non-randomized intervention study. evaluating the effectiveness of crizotinib in the treatment of children with severe form of neurofibromatosis type 2, in particular those who cannot undergo surgery and radiotherapy Medical Research Agency dr n. med. Marek Karwacki
Assessment of the frequency of persistent pulmonary hypertension of newborns in the group of newborns born between 32nd and 42th week of pregnancy treated with salbutamol Medical Research Agency dr hab. n. med. Renata Bokiniec
Education of doctors in the field of vaccination of children with autism spectrum disorders GlaxoSmithKline lek. Anna Piwowarczyk
CureGN: Glomerulonephropathy Network. National Institute of Health/University of Columbia dr hab. n. med. Krzysztof Mucha
An Assessment of nutritional status and eating patterns for children under 2-years old with cow’s milk protein allergy. NUTRICIA FOUNDATION dr Piotr Dziechciarz
Early and very early nutrition in acute pancreatitis NUTRICIA FOUNDATION dr hab. Aleksandra Banaszkiewicz
Effect of iron supplementation on psychomotor development of non-anemic exclusively or predominantly breastfed infants: randomized, controlled trial. NUTRICIA FOUNDATION dr Anna Chmielewska